SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020152
Filing Date
2021-08-16
Accepted
2021-08-16 16:06:20
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 652931
2 ex31-1.htm EX-31.1 7884
3 ex31-2.htm EX-31.2 11829
4 ex32-1.htm EX-32.1 7203
5 ex32-2.htm EX-32.2 7196
  Complete submission text file 0001493152-21-020152.txt   3436874

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20210630.xsd EX-101.SCH 32123
7 XBRL CALCULATION FILE ogen-20210630_cal.xml EX-101.CAL 36994
8 XBRL DEFINITION FILE ogen-20210630_def.xml EX-101.DEF 115987
9 XBRL LABEL FILE ogen-20210630_lab.xml EX-101.LAB 275743
10 XBRL PRESENTATION FILE ogen-20210630_pre.xml EX-101.PRE 209465
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 390588
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 211177974
SIC: 2834 Pharmaceutical Preparations